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Respiratory evaluation through volumetric capnography 
among grade III obese and eutrophic individuals: 
a comparative study
Débora Aparecida Oliveira ModenaI, Marcos Mello MoreiraII, Ilma Aparecida PaschoalIII, Mônica Corso PereiraIII, Luiz Cláudio 
MartinsIII, Everton CazzoVI, Elinton Adami ChaimV
Hospital de Clínicas, Universidade Estadual de Campinas (UNICAMP), Campinas (SP), Brazil
INTRODUCTION
Severely obese subjects develop various respiratory functional abnormalities, which may occur 
while awake, during sleep or while performing physical effort.1,2 There are obese individuals 
who hypoventilate during wakefulness, and this hypoventilation may cause hypoxemia and 
hypercapnia. These events characterize the diagnosis of alveolar hypoventilation in obese peo-
ple. Not all severely obese individuals hypoventilate when awake, and the factors that favor this 
situation are not entirely clear.3-5 Among the respiratory abnormalities in obese patients that 
appear during sleep, the most common of these is obstructive sleep apnea caused by obstruction 
of the air inlet in the upper airway during inspiration.4,5 
Obese subjects may also have difficulty performing physical effort because the accu-
mulation of fat in the chest and abdomen may hinder the increased ventilation required 
by physical exertion.4 Besides alveolar hypoventilation, obese patients can show abnor-
malities of respiratory patterns even when they are not exercising, and little is known 
about such patterns.4,5 
Pulse oximetry and measurement of arterial blood gases during wakefulness make it pos-
sible to diagnose situations of obesity hypoventilation syndrome.4,5 Polysomnography properly 
detects respiratory functional disorders that occur during sleep (obstructive apnea, central apnea 
and desaturation).4 However, spirometry requires physical effort and can show restrictive defects 
that are not necessarily related to involvement of the lungs. These restrictions may be caused by 
excessive accumulation of fat in the chest and abdomen that precludes proper spirometry maneu-
vers, which require physical effort.6-9
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BACKGROUND: Excess trunk body fat in obese individuals influences respiratory physiological function. 
The aims of this study were to compare volumetric capnography findings (VCap) between severely obese 
patients and normal-weight subjects and to assess whether there is any association between neck circum-
ference (NC), waist-hip ratio (WHR) and VCap among grade III obese individuals. 
DESIGN AND SETTING: Analytical observational case-matched cross-sectional study, University of Campinas. 
METHODS: This cross-sectional study compared VCap variables between 60 stage III obese patients and 
60 normal-weight individuals. 
RESULTS: In comparison with the normal-weight group, obese patients presented higher alveolar min-
ute volume (8.92 ± 4.94 versus 6.09 ± 2.2; P = < 0.0001), CO2 production (278 ± 91.0 versus 209 ± 60.23; 
P < 0.0001), expiratory tidal volume (807 ± 365 versus 624 ± 202; P = 0.005), CO2 production per breath 
(21.1 ± 9.7 versus 16.7 ± 6.16; P = 0.010) and peak expiratory flow (30.9 ± 11.9 versus 25.5 ± 9.13; P = 0.004). 
The end-expiratory CO2 (PetCO2) concentration (33.5 ± 4.88 versus 35.9 ± 3.79; P = 0.013) and the phase 
3 slope were normalized according to expired tidal volume (0.02 ± 0.05 versus 0.03 ± 0.01; P = 0.049) were 
lower in the obese group. 
CONCLUSIONS: The greater the NC was, the larger were the alveolar minute volume, anatomical dead 
space, CO2 production per minute and per breath and expiratory volume; whereas the smaller were the 
phase 2 slope (P2Slp), phase 3 slope (P3Slp) and pressure drop in the mouth during inspiration.
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Volumetric capnography (VCap), which consists of plotting 
the expired CO2 concentration against expired volume, is a bed-
side-validated method for measuring airway and alveolar dead-
space volumes, and ascertaining the pulmonary ventilation-per-
fusion relationships.6-10 In addition to its application in surgical 
and anesthetic settings, this method may be used among outpa-
tients with chronic respiratory diseases.11,12 The examination is 
performed during spontaneous breathing, and breath-to-breath 
measurements are collected, including tidal volume, minute vol-
ume and end tidal CO2. Besides these variables, each breath cycle 
produces a curve called a capnogram that has a shape similar to 
that of N2 washout.
Our hypothesis was that VCap might help in understanding 
abnormalities in respiratory patterns and lung function during 
rest among obese individuals.11-14
The aims of this study were to compare the VCap variables 
between severely obese patients and normal-weight subjects and 
to evaluate the existence of any correlation between neck circum-
ference (NC), waist/hip ratio (WHR) and VCap variables among 
obese patients. 
METHODS
This was an analytical observational case-matched cross-sectional 
study in which the subjects enrolled were grade III obese (body 
mass index, BMI ≥ 40 kg/m2) candidates for bariatric surgery at 
Hospital de Clínicas, University of Campinas (UNICAMP) and 
normal-weight controls (BMI 18.6-24.9) who were selected from 
the data bank of the Pulmonary Function Laboratory, UNICAMP. 
The subjects and controls were aged between 18  and 65 years 
old and were evaluated between August 2014 and July 2015. 
The study was approved by the local Research Ethics Committee. 
The following potential participants were excluded: active 
smokers or former smokers who had quit less than one year pre-
viously; individuals with chronic respiratory diseases unrelated to 
obesity; vulnerable groups (individuals who were mentally ill, insti-
tutionalized or aged below 18 years); and individuals who opted 
not to take part in the study. Both the obese and the non-obese 
participants reported that they did not have any respiratory dis-
eases (current or past) and were not on any respiratory medication.
The individuals selected were matched according to age, gen-
der and height and were divided into two groups: obese (group 1) 
and non-obese (group 2). In both groups, the variables initially 
collected and analyzed were age, gender and anthropometric mea-
surements (weight, height and BMI) (Table 1).
In the obese group, the variables of NC and WHR were also col-
lected and analyzed. The obese patients also answered the Berlin ques-
tionnaire (BQ), which evaluates the risk of development of obstructive 
sleep apnea syndrome (OSAS). Occurrences of hypertension were 
assessed in accordance with the Eighth National Joint Committee 
(JNC 8) criteria, i.e. individuals were considered to present hyper-
tension if at least three different blood pressure measurements were 
higher than 140/90 mmHg.15 The presence of type 2 diabetes mellitus 
(T2DM) was assessed in accordance with the criteria defined by the 
current guidelines of the International Diabetes Federation (IDF). 
The presence of T2DM was defined as the presence of any of the 
following abnormalities: fasting plasma glucose ≥ 126 mg/dl; 75 g 
oral glucose tolerance test with fasting plasma glucose ≥ 126 mg/dl 
and/or two-hour plasma glucose ≥ 200 mg/dl; glycated hemoglo-
bin (HbA1c) ≥ 6.5%; or random plasma glucose ≥ 200 mg/dl in the 
presence of classical diabetes symptoms.16
All the participants underwent VCap in the mornings at the 
Pulmonary Function Laboratory of UNICAMP. The device used 
was the oxy-capnograph and respiratory profile monitor (CO2SMOS 
Plus 8100 Dixtal/Novametrix; Respironics, Murrisville, PA, USA).
VCap is a technique that analyzes the pattern of CO2 elimination 
as a function of expired volume. It produces a curve called a capno-
gram, which represents the total amount of CO2 eliminated by the 
lungs during each breath. As would be expected, capnograms have 
the same shape as other gas elimination curves, with the advan-
tage that they are obtained using a gas that is produced normally 
by the body and is eliminated by the lungs.15
The VCap examinations took about 10 minutes each and were 
always performed by the same technician. Firstly, the participant 
was asked to sit in a comfortable position and rest for five min-
utes while instructions for the examination were provided. Before 
the examination, the patient was encouraged to drink water to 
prevent the discomfort that could be caused by mouth breathing 




Women 45 45 1.0
Men 15 15 1.0
Age (years)* 36 ± 10 36 ± 11 0.92
Weight (kg)* 141 ± 27 67.3 ± 11 < 0.0001
Height (m)* 1.66 ± 0.09 1.66 ± 0.08 0.74






High risk Low risk
45 15
Table 1. Comparison of anthropometric variables 
between obese patients (group 1) and non-obese subjects 
(group 2), and data on frequencies of comorbidities, 
Berlin questionnaire (BQ) results, neck circumference and 
waist-hip ratio in group 1
BMI = body mass index; NC = neck circumference; WHR = waist-hip ratio. 
*Data presented as mean ± standard deviation. Statistical difference when 
P < 0.05.
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(e.g. dry throat, coughing, etc.). After this, a nose clip was put in 
place to avoid air escape through the nostrils and the subject was 
asked to breathe room air regularly through a mouthpiece that he 
or she held with his or her dominant hand, which was connected 
to the capnograph sensors. The participant was asked to breathe 
normally for some seconds to adapt to this situation. 
Online digital recording of respiratory cycles was then started 
(Analysis Plus software), and this continued for five minutes. A pulse 
oximetry sensor was installed on the index finger. At the end of 
data collection, an offline sequence of the subjects’ respiratory 
cycles was selected to accommodate variation of < 15% for expira-
tory tidal volume and < 5% for partial pressure of CO2 concentra-
tion (PetCO2). Furthermore, sequences that showed phases 2 and 
3 slopes equal to zero were eliminated, along with outlier values.
Phases 2 and 3 slopes equal to zero can occur because, from time 
to time, the apparatus used removes the humidity from the sensor 
and, through this, the parameters are cleared. Outlier values occur 
because patients who are breathing spontaneously may make dif-
ferent respiratory efforts (e.g. sighing, coughing or speaking, etc.).
The patients were weighed using a digital scale that was appro-
priate for their size, with a maximum capacity of 300 kg and a resolu-
tion of 100 g, and height was ascertained using a wall-mounted sta-
diometer. From these measurements, BMI in kg/m2 was calculated. 
Waist circumference was determined using a measuring tape 
around the individual at the natural waist line, i.e. in the narrow-
est area between the chest and hip, at the midpoint between the 
last rib and the iliac crest. The readings were made at the end of 
expiration. Hip circumference was determined in the horizon-
tal plane at the level of the greatest posterior protuberance of the 
buttocks. The waist/hip ratio (WHR) was calculated using the for-
mula: WHR = waist circumference (cm)/hip circumference (cm). 
Both of these measurements were made with the patient standing, 
using a flexible measuring tape. Neck circumference was also mea-
sured using a flexible tape at the level of the laryngeal prominence. 
Statistical analysis
The baseline characteristics of the sample were presented in fre-
quency tables encompassing the categorical variables, as absolute 
(n) and percentage (%) frequencies. Continuous variables were 
presented as mean values with their respective standard devia-
tions (SD). Bivariate analyses on categorical variables were car-
ried out through the chi-square and Fisher’s exact tests. For com-
parisons of continuous measurements, the Mann-Whitney test 
was used. To study the relationship between the capnography 
measurements and, respectively, the neck circumference and 
the waist-to-hip ratio of the obese individuals, Spearman’s cor-
relation coefficient was used. The significance level used was 
5% (P  < 0.05). A Bonferroni adjustment was used for pair-
wise comparisons, to identify the significance within mean 
differences between correlations for each outcome (Bonferroni 
adjusted α  =  0.0015625 for Mann-Whitney comparisons and 
α = 0.0045 for Spearman’s correlations). To perform the analy-
ses, the Statistical Analysis System (SAS) software for Windows, 
version 9.2, was used.
Sample size estimation was performed through a single-pro-
portion formula with a 95% confidence interval. Precision was set 
at 10% and the calculated sample size was determined to be 60.
RESULTS
In the obese group, there were 45 women (75%) and 15 men 
(25%). Their mean age was 36 years, mean weight 141 kg, mean 
height 1.66 m, mean BMI 50.9 kg/m2, NC 44 cm and WHR 0.91. 
These two last anthropometric parameters were only measured 
in the group of obese individuals.
In this group, 27 (55%) had hypertension and 49 (81.7%) 
were diabetic. In the Berlin Questionnaire, 45 individuals (75%) 
presented a high risk of having OSAS and 15 (25%) presented 
a low risk.
In the non-obese group, 45 (75%) were women and 15 (25%) 
were men, with a mean age of 36 years, mean weight 67.3 kg, mean 
height 1.66 m and mean BMI 20.8 kg/m2. Table 1 summarizes the 
baseline characteristics of all the patients.
The obese patients presented alveolar minute volume (MV 
alv) (ml), production of CO2 per minute (VCO2) (ml/min), par-
tial pressure of end-tidal carbon dioxide (PetCO2) (mmHg), expi-
ratory volume (Ve) (ml), peak expiratory flow (PEF) (l/min), pro-
duction of CO2 per breath (VCO2/br) (ml/breath) and phase 3 
slope normalized according to end-tidal partial pressure of CO2 
(P3Slp/Ve) that were statistically different (P < 0.05) from those of 
the normal-weight controls. After applying the Holm-Bonferroni 
correction, MV alv (ml) and VCO2 (ml/min) remained significantly 
higher in the obese group (P < 0.0015625). The capnography vari-
ables are shown in Table 2.
In the obese individuals, WHR did not present any correla-
tion with VCap measurements. On the other hand, in correlation 
analyses between NC measurements and capnography variables 
(Table 3), there were significant correlations for the following 
variables: the greater the NC was, the larger were the alveolar 
minute volume (MV alv), the anatomical dead space (VD), the 
production of CO2 per minute (VCO2), the inspiratory volume 
(Vi), the expiratory volume (Ve), the peak expiratory flow (PEF) 
and the production of CO2 per breath (VCO2/br); whereas the 
greater the NC was, the smaller were the phase 2 slope (P2Slp), 
the phase 3 slope (P3Slp) and the pressure drop in the mouth 
during negative inspiratory pressure (NIP). After applying the 
Bonferroni adjustment (P < 0.0045), NIP, P3Slp and VCO2/br no 
longer presented significant correlations, while the other vari-
ables remained significant.
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DISCUSSION
The obese patients in this study had significantly greater alveo-
lar minute volume (MV alv) and expired volume of CO2 (average 
per minute) or VCO2. These results (greater MV alv with equal 
respiratory rate) suggest that obese patients possibly have more 
efficient ventilation during tidal breathing, since the VCap mea-
surements are made during several minutes of quiet breathing. 
These measurements do not require forced expiration, as spirom-
etry does. Tidal volume and alveolar minute ventilation may be 
higher in order to match the higher needs of a greater body mass. 
Nevertheless, the low mean PetCO2 and P3Slp/Ve may indicate 
that the obese group presented a larger alveolated area. The com-
parison between the two groups (obese versus non-obese sub-
jects) revealed that there were no statistical differences regarding 
age and height. The respiratory rate and the dead volume of the 
airways were similar in the two groups.
The reductions in forced vital capacity that are detected in obese 
patients through spirometry may, at least in part, be related to the 
difficulties in using expiratory abdominal muscles due to fat accu-
mulation in this area. The obese patients in the present study did not 
perform spirometry because this was not part of the study protocol.
Wei et al. found that the lungs of obese patients had higher 
capacity to diffuse carbon monoxide and attributed this result to 
the higher blood flow to the lungs that obese subjects may have.14 
However, our results may suggest that their greater capacity for 
diffusion may be due to a real increase in alveolar surface area.
The peripheral airspaces have been termed the silent lung 
zone because conventional lung function tests are unable to detect 
their involvement in disease processes. Inert gases such as helium 
(He), nitrogen (N2) and sulfur hexafluoride (SF6) have been used 
to study these areas and the elimination curves that they produce 
during each expiration depict concentrations of the gas at dif-
ferent volumes until all the expiratory volume has been expired. 
Irrespective of the gas used, all curves have the same shape and, 
on each of them, three phases can be identified: phase 1, with very 
low concentrations of the gas, corresponds to the elimination of 
the air from the anatomical dead space; phase 2, which is gener-
ally a steep upward line, represents the growing concentration of 
the gas that is eliminated from proximal alveolated air spaces; and 




Average SD Median Average SD Median
RR (cpm) 14 4.94 14.1 13 3.76 13.4 0.365
HR (bpm) 74 13.7 74.7 77 11.3 76.5 0.198
SpO2 (%) 97 1.02 97.4 97 0.64 97.8 0.155
VD (aw) (ml) 134 35.5 134 137 28.4 131 0.639
PeCO2 (mmHg) 24.2 3.56 24.3 24 3.49 24.1 0.661
Vi (ml) 760 349 717 622 203 590 0.053
Ti (sec) 1.91 0.66 1.66 1.87 0.56 1.72 0.950
Te (sec) 2.66 0.98 2.46 2.87 0.97 2.81 0.129
PIF (l/min) 35.1 13.3 32.8 31.8 8.7 31.3 0.307
RSBI (VT/RR) 26.4 21.9 21.2 25.7 14.2 23.4 0.430
P2Slp (mmHg/l) 333 156 297 337 82.5 331 0.224
P3Slp (mmHg/l) 10.2 9.19 7.32 10.9 15.0 8.16 0.286
P3Slp/PetCO2 
(mmHg)
0.3 0.24 0.24 0.31 0.48 0.23 0.803
NIP (cmH2O) -0.36 0.65 -0.05 -0.7 4.27 -0.02 0.243
MV alv (ml) 8.92 4.15 8 6.09 2.2 5.3 < 0.0001
VCO2 (ml/min) 278 91.0 268 209 60.2 199 < 0.0001
PetCO2 (mmHg) 33.5 4.88 33.9 35.9 3.79 35.8 0.013
Ve (ml) 807 365 763 624 202 587 0.005
PEF (l/min) 30.9 11.9 28.6 25.5 9.13 23.3 0.004
VCO2/br 
(ml/breath)
21.1 9.7 19.3 16.7 6.16 15.7 0.010
P3Slp/Ve 0.02 0.05 0.01 0.03 0.09 0.01 0.049
Table 2. Distribution of the variables of age, anthropometry and 
volumetric capnography (VCap) among patients with and without obesity
RR = respiratory rate; HR = heart rate; SpO2 = oxygen saturation; VD 
(aw) = anatomical dead space; PeCO2 = mean end-tidal partial pressure of CO2; 
Vi = inspiratory tidal volume; Ti = inspiratory time; Te = expiratory time; PIF = peak 
inspiratory flow; RSBI = Tobin index; VT = tidal volume; P2Slp = phase 2 slope; 
P3Slp = phase 3 slope; P3Slp/PetCO2 = phase 3 slope normalized according to end-
tidal partial pressure of CO2; NIP = negative inspiratory pressure; MV alv = alveolar 
minute volume; VCO2 = CO2 production; PetCO2 = end-tidal partial pressure of 
CO2; Ve = expiratory tidal volume; PEF = peak expiratory flow; VCO2/br = CO2 
production per breath; P3Slp/Ve = phase 3 slope normalized according to expired 
tidal volume. Results are presented as means, medians and standard deviations. 
P-value for the Mann-Whitney test comparing group 1 (obese) with group 2 (non-
obese) after the Bonferroni adjustment; P < 0.0015625.
VCap variables r P
MV alv (l) 0.43 0.0006
VD (aw) (ml) 0.45 0.0003
VCO2 (ml/min) 0.48 < 0.0001
Vi (ml) 0.36 0.0045
Ve (ml) 0.36 0.0041
PEF (l/min) 0.40 0.0017
VCO2/br (ml/breath) 0.34 0.0082
P2Slp (mmHg/l) -0.38 0.0027
P3Slp /Ve -0.29 0.0242
PIF (l/min) 0.47 < 0.0001
NIP (cmH2O) -0.33 0.0100
Table 3. Analysis on correlations between neck circumference 
(NC) and volumetric capnography (VCap) variables among 
obese individuals (Group 1)
MV alv (L) = alveolar minute volume; VD (aw) (ml) = anatomical 
dead space; VCO2 (ml/min) = CO2 production; Vi (mL) = inspiratory 
tidal volume; Ve (ml) = expiratory tidal volume; PEF (l/min) = peak 
expiratory flow; VCO2/br (ml/breath) = CO2 production per breath; 
P2Slp (mmHg/l) = phase 2 slope; P3Slp (mmHg/l) = phase 3 slope; 
PIF (l/min) = peak inspiratory flow; NIP (cmH2O) = negative inspiratory 
pressure. P-value results regarding the Spearman correlation test are 
from correlations between NC and WHR measurements and the VCap 
variables of the obese individuals, adjusted in accordance with the 
Bonferroni correction: P < 0.0045.
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of the gas from most of the alveoli in the lungs. The phase 3 slope 
(mmHg/l) is an important feature of gas washout curves and con-
tains information about gas transportation in the alveolated air-
ways of the lung periphery. It varies in many pathological condi-
tions of the lungs.14-21
Phase 3 (mmHg/l) of the VCap represents the elimination 
of CO2 from most of the alveoli and, in normal individuals, it is 
almost a plateau, with a slight upward slope. The phase 3 slope 
(P3Slp) should therefore be small. 
Because of the very small convective velocities in the lung 
periphery, gas transportation through diffusion is the dominant 
mechanism in acinar air spaces. Steepened phase 3 slopes may 
represent increased diffusional resistance in the peripheral lung. 
These steepened slopes occur when breathing involves a small-
er-than-normal maximum interfacial area between the tidal vol-
ume and the functional residual capacity (FRC) during a breathing 
interval. Small tidal volumes produce steeper slopes because the 
inhaled air penetrates to shallower-than-normal depths in the lung 
and therefore encounters smaller-than-normal maximum interfa-
cial areas and longer gas-phase diffusion paths.22-24 Hence, there is 
a need to normalize phase 3 slopes when comparing subjects with 
significantly different expired volumes.11,12 
In a paper on VCap in children, Ream et al.25 postulated that 
the observed decrease in normalized phase 3 slopes of CO2 wash-
out curves with increasing age was due to an increase in the inter-
face between functional residual capacity (FRC) and tidal volume 
(VT), with lung growth in children.
It seems that, taking into account the significantly smaller 
normalized values of phase 3 slopes in obese patients, a hypoth-
esis can be put forward: obese patients may have larger or more 
efficient alveolated airspaces than do non-obese subjects. The cor-
relations between NC values and capnography variables that were 
found to be significant are in agreement with the hypothesis put 
forward here, i.e. that the greater the body mass was (reflected in 
this analysis by greater NC), the larger were the lungs of the obese 
subjects who participated in this study.
Human leptin is a 16-kDa protein of 167 amino acids and was 
the first fat cell-derived hormone to be discovered.26,27 Leptin is 
produced primarily in the adipocytes of white adipose tissue. In the 
fetal lungs, leptin is induced in a special phenotype of alveolar inter-
stitial fibroblasts, called lipofibroblasts, through the action of the 
parathyroid hormone-related protein (PTHrP), which is secreted 
by the alveolar epithelium under moderate stretching. The leptin 
from the mesenchyme, in turn, acts back on the epithelium at the 
leptin receptor carried in the alveolar type II pneumocytes and 
induces surfactant expression, which is of paramount importance 
for lung function.28-30 Leptin-deficient mice show altered postna-
tal lung development. They have reduced lung volume and alveo-
lar surface area and the alveolar size does not increase with age.31
Leptin levels are paradoxically increased in situations of obe-
sity.32 Although, as a circulating signal, leptin reduces appetite, 
obese individuals generally exhibit higher circulating concentra-
tions of leptin than do normal-weight individuals, because of their 
higher percentage of body fat. The expected responses to high 
levels of leptin are decreased calorie intake and increased energy 
expenditure. Most obese humans are probably insensitive to this 
action by leptin, and behave similarly to type 2 diabetic patients 
who show resistance to the action of insulin. 
The excess leptin present in obese subjects may at least partly 
explain the apparently larger lungs detected through VCap in 
these patients. Fat deposits in the neck and abdomen may display 
a mechanical effect on the chest and may hinder chest mobility 
during forced expiration and possibly also during spontaneous ven-
tilation, with consequences for lung function. This has also been 
observed in other studies,33-37 such as the increased risk of devel-
oping lung-base atelectasis in obese individuals due to mechani-
cal compression exerted by the abdomen in the region.38 Greater 
NC can cause increased airflow resistance, especially when NC is 
greater than 40 cm, and this can result in hypoventilation. 
None of the obese patients in the present study, whose BMI 
was greater than 52, had obesity hypoventilation syndrome (OHS), 
although 45 of them showed a high-risk result from the Berlin 
questionnaire for obstructive sleep apnea syndrome (OSAS).39 
The scores in the Berlin questionnaire were positively correlated 
with neck circumference. No sleep studies were available for 
these individuals.
The hypothesis that these individuals may have had a larger 
alveolar-capillary membrane might serve as a possible reason for 
the absence of CO2 retention. Recent reports have shown that alve-
olar growth continues from childhood into adolescence in humans 
and other mammals.33-35 The lungs of obese patients who were 
obese children may have been exposed to higher levels of leptin 
during a period when the alveoli were actively growing. Obesity 
hypoventilation syndrome might perhaps be more commonly 
found among obese subjects whose weight gain occurred later in 
life, a hypothesis that awaits further investigation.
Ferreira et al.40 analyzed obese and normal-weight children 
without asthma and reported that the obese children had greater 
lung volumes, shown through volumetric capnography, and lower 
values for the ratio between the phase 3 slope of the volumetric cap-
nogram and the expired volume (P3Slp/Ve). These findings were 
consistent with the results obtained by Ream et al.25 who evaluated 
infants, children and adolescents and found lower values for P3Slp 
in individuals with higher Ve, and a negative association between 
P3Slp, body weight and body surface area. Growth increased the 
number of alveoli in the lungs and reduced the phase 3 slope on 
capnograms. The obese children in the study by Ferreira et al. 
seemed to have larger lungs. 
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Limitations and strength
This study has some limitations. Carbon monoxide diffusion was 
not performed on the patients of the present study because we 
did not have the equipment to do this. This measurement could 
have helped to rule out alterations in carbon monoxide diffusion 
as the cause of our findings. The NC and WHR data relating to 
the controls were not available because the data were collected 
from a database. Spirometry data were not available because the 
obese patients were in the process of losing weight and would 
undergo spirometry after achieving a predetermined goal. It was 
not possible to evaluate whether exposure to toxic agents such as 
tobacco might have influenced respiratory function in the two 
groups, since we did not have this information in the database 
relating to the non-obese group.
Our findings may contribute towards understanding the com-
plex range of alterations to respiratory function that are seen in 
very obese patients. They also raise the intriguing possibility that 
some obese individuals may undergo changes to the alveolar-cap-
illary membrane that enable greater efficiency of CO2 elimination. 
Knowing the leptin levels in these patients might have contributed 
towards investigating this hypothesis.
CONCLUSION
Volumetric capnography was capable of detecting particular 
characteristics of lung structure and function in morbidly obese 
patients, among which some had not previously been shown. 
It identified changes to various respiratory parameters, in com-
parison with a normal-weight control group. The greater the NC 
was, the larger were the alveolar minute volume, anatomical dead 
space, CO2 production per minute and per breath and expira-
tory volume; whereas the smaller were the phase 2 slope (P2Slp), 
phase 3 slope (P3Slp) and pressure drop in the mouth during 
inspiration. Some of these changes were related to possibly larger 
lungs in obese patients and others to their larger NC. The com-
bination of larger lungs and absence of hypoventilation makes us 
speculate that these two occurrences may be linked. 
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